Skip to main content
. 2022 Aug 16;14(8):1711. doi: 10.3390/pharmaceutics14081711

Table 5.

Pharmacokinetic profile of β–sito–Alg/Ch/NPs and β–sito–suspension.

Formulation AUC0−t (μg × h/mL) Tmax (h) Cmax t1/2 (h) ke (h−1)
β–sito–Alg/Ch/NPs 1080 ± 1 4 180 ± 0.02 5 ± 0.1 0.2 ± 0.01
β–sito–suspension 317 ± 1 4 56 ± 0.2 2 ± 0.3 0.3 ± 0.02